Ameritas Investment Partners, Inc. Abbott Laboratories Transaction History

Ameritas Investment Partners, Inc.

$2.98 Billion
Q3 2024

A detailed history of Ameritas Investment Partners, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Ameritas Investment Partners, Inc. holds 54,768 shares of ABT stock, worth $6.35 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares

54,768

Previous 60,890 10.05%

Holding current value

$6.35 Million

Previous $6.33 Million 1.31%

% of portfolio

0.21%

Previous 0.22%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$100.07 - $118.13 $612,628 - $723,191	-6,122 Reduced 10.05%	54,768 $6.24 Million
Q2 2024 Aug 13, 2024	SELL	$100.73 - $112.44 $16,016 - $17,877	-159 Reduced 0.26%	60,890 $6.33 Million
Q1 2024 May 13, 2024	SELL	$109.52 - $120.96 $237,767 - $262,604	-2,171 Reduced 3.43%	61,049 $6.94 Million
Q4 2023 Feb 14, 2024	BUY	$90.19 - $110.4 $45,365 - $55,531	503 Added 0.8%	63,220 $6.96 Million
Q3 2023 Nov 13, 2023	BUY	$95.53 - $114.62 $212,172 - $254,571	2,221 Added 3.67%	62,717 $6.07 Million
Q2 2023 Aug 11, 2023	SELL	$100.78 - $112.29 $376,816 - $419,852	-3,739 Reduced 5.82%	60,496 $6.6 Million
Q1 2023 May 10, 2023	SELL	$96.86 - $114.01 $12,688 - $14,935	-131 Reduced 0.2%	64,235 $6.5 Million
Q4 2022 Feb 13, 2023	SELL	$95.06 - $111.52 $45,343 - $53,195	-477 Reduced 0.74%	64,366 $7.07 Million
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $74,698 - $86,487	772 Added 1.2%	64,843 $6.27 Million
Q2 2022 Aug 12, 2022	SELL	$102.07 - $123.37 $88,800 - $107,331	-870 Reduced 1.34%	64,071 $6.96 Million
Q1 2022 May 13, 2022	BUY	$114.02 - $139.04 $278,778 - $339,952	2,445 Added 3.91%	64,941 $7.69 Million
Q4 2021 Feb 11, 2022	BUY	$115.53 - $141.46 $3,928 - $4,809	34 Added 0.05%	62,496 $8.8 Million
Q3 2021 Nov 15, 2021	SELL	$116.66 - $129.06 $47,947 - $53,043	-411 Reduced 0.65%	62,462 $7.38 Million
Q2 2021 Aug 06, 2021	BUY	$105.79 - $124.53 $8,886 - $10,460	84 Added 0.13%	62,873 $7.29 Million
Q1 2021 May 14, 2021	SELL	$108.84 - $128.23 $106,336 - $125,280	-977 Reduced 1.53%	62,789 $7.21 Million
Q4 2020 Feb 12, 2021	SELL	$105.0 - $114.42 $481,635 - $524,844	-4,587 Reduced 6.71%	63,766 $6.98 Million
Q3 2020 Nov 13, 2020	SELL	$91.64 - $111.29 $232,673 - $282,565	-2,539 Reduced 3.58%	68,353 $7.44 Million
Q2 2020 Aug 05, 2020	SELL	$76.57 - $98.0 $278,408 - $356,328	-3,636 Reduced 4.88%	70,892 $6.48 Million
Q1 2020 May 13, 2020	BUY	$62.82 - $91.86 $18,154 - $26,547	289 Added 0.39%	74,528 $5.88 Million
Q4 2019 Feb 13, 2020	SELL	$78.51 - $87.4 $600,994 - $669,047	-7,655 Reduced 9.35%	74,239 $6.45 Million
Q3 2019 Nov 14, 2019	SELL	$81.84 - $88.74 $40,428 - $43,837	-494 Reduced 0.6%	81,894 $6.85 Million
Q2 2019 Aug 14, 2019	SELL	$72.88 - $85.0 $45,695 - $53,295	-627 Reduced 0.76%	82,388 $6.93 Million
Q1 2019 May 15, 2019	SELL	$66.22 - $80.06 $77,808 - $94,070	-1,175 Reduced 1.4%	83,015 $6.64 Million
Q4 2018 Feb 12, 2019	BUY	$65.56 - $74.27 $100,503 - $113,855	1,533 Added 1.85%	84,190 $6.09 Million
Q3 2018 Nov 13, 2018	SELL	$60.81 - $73.36 $54,181 - $65,363	-891 Reduced 1.07%	82,657 $6.06 Million
Q2 2018 Aug 13, 2018	SELL	$57.57 - $63.54 $235,691 - $260,132	-4,094 Reduced 4.67%	83,548 $5.09 Million
Q1 2018 May 15, 2018	SELL	$56.27 - $63.62 $483,021 - $546,114	-8,584 Reduced 8.92%	87,642 $5.25 Million
Q4 2017 Feb 14, 2018	SELL	$53.68 - $57.47 $462,667 - $495,333	-8,619 Reduced 8.22%	96,226 $6.6 Million
Q3 2017 Nov 15, 2017	SELL	$48.06 - $53.64 $13,456 - $15,019	-280 Reduced 0.27%	104,845 $5.5 Million
Q2 2017 Aug 15, 2017	BUY	N/A	105,125	105,125 $5.11 Million

Others Institutions Holding ABT

# of Institutions

3,187

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $203B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.

Account

Ameritas Investment Partners, Inc. Abbott Laboratories Transaction History